120 related articles for article (PubMed ID: 32895127)
1. [Establishment of a vimentin knockout and HIV-1 gp120 transgenic mouse model].
He X; Peng L; Zhang B; Li L; Wu C; Xiao H; Yang W; Zeng Z; Yang X; Long M; Cao H; Huang S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):519-524. PubMed ID: 32895127
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of a gp120 transgenic mouse model with
Hu T; Gong Z; Wan Y; Li Y; Gao X; Lun J; Huang S; Cao H
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1184-1191. PubMed ID: 32895175
[TBL] [Abstract][Full Text] [Related]
3. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Thaney VE; Sanchez AB; Fields JA; Minassian A; Young JW; Maung R; Kaul M
J Neurovirol; 2018 Apr; 24(2):156-167. PubMed ID: 29075998
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity.
Fields JA; Overk C; Adame A; Florio J; Mante M; Pineda A; Desplats P; Rockenstein E; Achim C; Masliah E
J Neuroinflammation; 2016 May; 13(1):120. PubMed ID: 27220536
[TBL] [Abstract][Full Text] [Related]
6. Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein.
Mucke L; Abraham CR; Ruppe MD; Rockenstein EM; Toggas SM; Mallory M; Alford M; Masliah E
J Exp Med; 1995 Apr; 181(4):1551-6. PubMed ID: 7699335
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.
Toggas SM; Masliah E; Rockenstein EM; Rall GF; Abraham CR; Mucke L
Nature; 1994 Jan; 367(6459):188-93. PubMed ID: 8114918
[TBL] [Abstract][Full Text] [Related]
8. An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120.
Kang Y; Melo EF; Scott DW
Eur J Immunol; 1998 Aug; 28(8):2253-64. PubMed ID: 9710203
[TBL] [Abstract][Full Text] [Related]
9. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice.
Toneatto S; Finco O; van der Putten H; Abrignani S; Annunziata P
AIDS; 1999 Dec; 13(17):2343-8. PubMed ID: 10597775
[TBL] [Abstract][Full Text] [Related]
10. Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice.
Cioni C; Annunziata P
Neurosci Lett; 2002 Sep; 330(3):299-301. PubMed ID: 12270651
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
Kesby JP; Markou A; Semenova S;
Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
[TBL] [Abstract][Full Text] [Related]
12. Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice.
Melendez RI; Roman C; Capo-Velez CM; Lasalde-Dominicci JA
J Neurovirol; 2016 Jun; 22(3):358-65. PubMed ID: 26567011
[TBL] [Abstract][Full Text] [Related]
13. Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration.
Banerjee S; Liao L; Russo R; Nakamura T; McKercher SR; Okamoto S; Haun F; Nikzad R; Zaidi R; Holland E; Eroshkin A; Yates JR; Lipton SA
Exp Neurol; 2012 Aug; 236(2):298-306. PubMed ID: 22575597
[TBL] [Abstract][Full Text] [Related]
14. Expression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala.
Bachis A; Forcelli P; Masliah E; Campbell L; Mocchetti I
Brain Behav Immun; 2016 May; 54():170-177. PubMed ID: 26845379
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis.
Wyss-Coray T; Masliah E; Toggas SM; Rockenstein EM; Brooker MJ; Lee HS; Mucke L
J Clin Invest; 1996 Feb; 97(3):789-98. PubMed ID: 8609236
[TBL] [Abstract][Full Text] [Related]
16. The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders.
Capó-Vélez CM; Morales-Vargas B; García-González A; Grajales-Reyes JG; Delgado-Vélez M; Madera B; Báez-Pagán CA; Quesada O; Lasalde-Dominicci JA
Sci Rep; 2018 Jan; 8(1):1829. PubMed ID: 29379089
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of skin from human immunodeficiency virus type 1-transgenic mice to normal congenic mice results in graft rejection.
Dumois JA; VanderVegt FP; Kopp JB; Marinos NJ; Rooney JF; Notkins AL
J Infect Dis; 1995 Jul; 172(1):232-4. PubMed ID: 7797918
[TBL] [Abstract][Full Text] [Related]
18. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4.
Wieder KJ; Chatis P; Boltax J; Wieder I; Nuovo G; Strom TB
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):867-76. PubMed ID: 8798971
[TBL] [Abstract][Full Text] [Related]
20. Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120.
Seagal J; Spectorman E; Gershoni JM; Denisova GF
Transgenic Res; 2001 Apr; 10(2):113-20. PubMed ID: 11305358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
